Physician

Ahad Aftab Khan Lodhi, M.D.

According to 2025 Medicare claims, Ahad Lodhi, M.D. (NPI: 1982833851) practices nephrology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is THE KIDNEY CLINIC LLC (NPI: 1760665129; TIN: 11-3828737) and primary practice location at 70601-8383.

Lodhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 808 traditional Medicare patients, billed 3,741 HCPCS/CPT codes, and received $340,970 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,583 prescription claims across 574 beneficiaries totaling $498,629 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2017 DME data shows 11 claims. Open Payments data shows 36 records totaling $829. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $24,770 to $340,970. Similarly, Part D prescription costs have moved sharply higher in recent years, from $40,684 to $498,629. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	100	369	$24,770
2016	401	1,602	$129,812
2017	646	2,551	$222,226
2018	752	3,177	$280,156
2019	921	3,988	$347,679
2020	896	3,523	$325,173
2021	818	3,252	$354,099
2022	819	3,827	$400,551
2023	819	3,634	$400,391
2024	808	3,741	$340,970

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	281	$40,684
2016	214	1,168	$223,662
2017	313	1,841	$291,719
2018	359	2,282	$273,751
2019	398	2,353	$149,241
2020	409	2,360	$173,049
2021	423	2,575	$208,992
2022	434	2,722	$403,792
2023	532	3,163	$993,570
2024	574	3,583	$498,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$234
2017	N/R	11	$716
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	125	270	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	427	616	$79
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	160	298	$53
90935	Hemodialysis procedure with physician evaluation	97	319	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	433	582	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	218	7,827	$144,080
Jardiance	Empagliflozin	65	2,880	$55,154
Velphoro	Sucroferric Oxyhydroxide	14	600	$48,811
Veltassa	Patiromer Calcium Sorbitex	40	1,620	$48,457
Auryxia	Ferric Citrate	14	720	$22,917

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$829	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahad Aftab Khan Lodhi, M.D.?

Tedicare shows public-source Medicare data for Ahad Aftab Khan Lodhi, M.D. (NPI 1982833851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahad Aftab Khan Lodhi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahad Aftab Khan Lodhi, M.D.?

Ahad Aftab Khan Lodhi, M.D. is linked to THE KIDNEY CLINIC LLC (billing NPI 1760665129) in the available physician profile data.

Does Ahad Aftab Khan Lodhi, M.D. have Open Payments data?

Ahad Aftab Khan Lodhi, M.D. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.